These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 3000501)

  • 1. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
    Porreca F; LoPresti D; Ward SJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved assays for the assessment of kappa- and delta-properties of opioid ligands.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Nov; 85(2):163-70. PubMed ID: 6295778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
    Ward SJ; LoPresti D; James DW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible selective blockade of kappa-opioid receptors in the guinea-pig ileum.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1986 Sep; 129(1-2):19-24. PubMed ID: 3021476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.
    Martín MI; Alfaro MJ; Goicoechea C; Colado MI
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
    Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
    Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of opioid receptor types on post-tetanic twitch inhibition in isolated guinea-pig ileal longitudinal muscle.
    Ozaki M; Miyamoto Y; Kishioka S; Masuda Y; Yamamoto H
    Neuropharmacology; 1994 May; 33(5):671-9. PubMed ID: 7936103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
    Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
    Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1986 Oct; 29(10):1868-71. PubMed ID: 3020246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa.
    Yamamoto LT; Horie S; Takayama H; Aimi N; Sakai S; Yano S; Shan J; Pang PK; Ponglux D; Watanabe K
    Gen Pharmacol; 1999 Jul; 33(1):73-81. PubMed ID: 10428019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of intrinsic activity to the action of opioids in vitro.
    Miller L; Shaw JS; Whiting EM
    Br J Pharmacol; 1986 Mar; 87(3):595-601. PubMed ID: 3801765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Jun; 80(4):377-84. PubMed ID: 6286325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.